Short-term effectiveness of bivalent COVID-19 mRNA booster vaccinations in the veterans' health administration using self-controlled risk interval and test-negative case-control designs

被引：0

作者：

Korves, Caroline ^{[1
]}

Izurieta, Hector S. ^{[2
]}

Balajee, Abirami S. ^{[1
]}

Zwain, Gabrielle M. ^{[1
]}

Smith, Jeremy ^{[1
]}

Graham, David J. ^{[3
]}

Young-Xu, Yinong ^{[4
]}

机构：

[1] White River Junction Vet Affairs Med Ctr, White River Jct, VT USA

[2] Food & Drug Adm, Off Vaccines Res & Review, Ctr Biol Evaluat & Res, Silver Spring, MD USA

[3] US FDA, Off Surveillance & Epidemiol, Ctr Drug Evaluat & Res, Silver Spring, MD USA

[4] Vet Affairs Med Ctr, White River Jct, VT USA

来源：

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2023年 / 32卷

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

186

引用

页码：79 / 79

页数：1

共 50 条

[41] Relative vaccine effectiveness of mRNA COVID-19 boosters in people aged at least 75 years during the spring-summer (monovalent vaccine) and autumn- winter (bivalent vaccine) booster campaigns: a prospective test negative case-control study, United Kingdom, 2022
Chatzilena, Anastasia
Hyams, Catherine
Challen, Rob
Marlow, Robin
King, Jade
Adegbite, David
Kinney, Jane
Clout, Madeleine
Maskell, Nick
Oliver, Jennifer
Finn, Adam
Danon, Leon
EUROSURVEILLANCE, 2023, 28 (48)
[42] Effectiveness of heterologous third and fourth dose COVID-19 vaccine schedules for SARS-CoV-2 infection during delta and omicron predominance in Thailand: a test-negative, case-control study
Intawong, Kannikar
Chariyalertsak, Suwat
Chalom, Kittipan
Wonghirundecha, Thanachol
Kowatcharakul, Woravut
Thongprachum, Aksara
Chotirosniramit, Narain
Teacharak, Worachet
Khammawan, Pimpinan
Waneesorn, Jarurin
Iamsirithaworn, Sopon
LANCET REGIONAL HEALTH - SOUTHEAST ASIA, 2023, 10
[43] Effectiveness of mRNA boosters after homologous primary series with BNT162b2 or ChAdOx1 against symptomatic infection and severe COVID-19 in Brazil and Scotland: A test-negative design case-control study
Cerqueira-Silva, Thiago
Shah, Syed Ahmar
Robertson, Chris
Sanchez, Mauro
Katikireddi, Srinivasa Vittal
Oliveira, Vinicius de Araujo
Paixao, Enny S.
Rudan, Igor
Bertoldo Junior, Juracy
Penna, Gerson O.
Pearce, Neil
Werneck, Guilherme Loureiro
Barreto, Mauricio L.
Boaventura, Viviane S.
Sheikh, Aziz
Barral-Netto, Manoel
PLOS MEDICINE, 2023, 20 (01)
[44] Safety of monovalent and bivalent BNT162b2 mRNA COVID-19 vaccine boosters in at-risk populations in Israel: a large-scale, retrospective, self-controlled case series study
Yamin, Dan
Yechezkel, Matan
Arbel, Ronen
Beckenstein, Tanya
Sergienko, Ruslan
Duskin-Bitan, Hadar
Yaron, Shlomit
Peretz, Alon
Netzer, Doron
Shmueli, Erez
LANCET INFECTIOUS DISEASES, 2023, 23 (10): : 1130 - 1142
[45] Effectiveness of COVID-19 mRNA Vaccines in Preventing COVID-19-Associated Outpatient Visits and Hospitalizations Among American Indian and Alaska Native Persons, January-November 2021: A Test-Negative Case-Control Analysis Using Surveillance Data (vol 10, ofad172, 2023)
Lutz, C. S.
Hartman, R. H.
Vigil, D. E.
OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (05):
[46] Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control study
Hyams, Catherine
Marlow, Robin
Maseko, Zandile
King, Jade
Ward, Lana
Fox, Kazminder
Heath, Robyn
Tuner, Anabella
Friedrich, Zsolt
Morrison, Leigh
Ruffino, Gabriella
Antico, Rupert
Adegbite, David
Szasz-Benczur, Zsuzsa
Gonzalez, Maria Garcia
Oliver, Jennifer
Danon, Leon
Finn, Adam
LANCET INFECTIOUS DISEASES, 2021, 21 (11): : 1539 - 1548
[47] Vaccine effectiveness of two-dose BNT162b2 against symptomatic and severe COVID-19 among adolescents in Brazil and Scotland over time: a test-negative case-control study
Florentino, Pilar T., V
Millington, Tristan
Cerqueira-Silva, Thiago
Robertson, Chris
Oliveira, Vinicius de Araujo
Junior, Juracy B. S.
Alves, Flavia J. O.
Penna, Gerson O.
Katikireddi, Srinivasa Vital
Boaventura, Viviane S.
Werneck, Guilherme L.
Pearce, Neil
McCowan, Colin
Sullivan, Christopher
Agrawal, Utkarsh
Grange, Zoe
Ritchie, Lewis D.
Simpson, Colin R.
Sheikh, Aziz
Barreto, Mauricio L.
Rudan, Igor
Barral-Netto, Manoel
Paixao, Enny S.
LANCET INFECTIOUS DISEASES, 2022, 22 (11): : 1577 - 1586
[48] BBIBP-CorV vaccine effectiveness against COVID-19 in patients aged 60 years and older during the Delta-dominant period in the Federation of Bosnia and Herzegovina, a test-negative case-control study
Musa, Sanjin
Merdrignac, Lore
Skocibusic, Sinisa
Nedic, Rozalija
Cilovic-Lagarija, Seila
Kissling, Esther
VACCINE, 2024, 42 (15) : 3467 - 3473
[49] Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccination With BNT162b2 Increased Risk of Bell's Palsy: A Nested Case-Control and Self-Controlled Case Series Study
Wan, Eric Yuk Fai
Chui, Celine Sze Ling
Ng, Vanessa Wai Sei
Wang, Yuan
Yan, Vincent Ka Chun
Lam, Ivan Chun Hang
Fan, Min
Lai, Francisco Tsz Tsun
Chan, Esther Wai Yin
Li, Xue
Wong, Carlos King Ho
Chung, Raccoon Ka Cheong
Cowling, Benjamin John
Fong, Wing Chi
Lau, Alexander Yuk Lun
Mok, Vincent Chung Tong
Chan, Frank Ling Fung
Lee, Cheuk Kwong
Chan, Lot Sze Tao
Lo, Dawin
Lau, Kui Kai
Hung, Ivan Fan Ngai
Lau, Chak Sing
Leung, Gabriel Matthew
Wong, Ian Chi Kei
CLINICAL INFECTIOUS DISEASES, 2023, 76 (03) : E291 - E298
[50] Effectiveness of the BNT162b2 XBB.1.5-adapted vaccine against COVID-19 hospitalization related to the JN.1 variant in Europe: a test-negative case-control study using the id.DRIVE platform
Nguyen, Jennifer L.
Mitratza, Marianna
Volkman, Hannah R.
de Munter, Leonie
Tran, Thao Mai Phuong
Marques, Catia
Mustapha, Mustapha
Valluri, Srinivas
Yang, Jingyan
Anton, Andres
Casas, Irma
Conde-Sousa, Eduardo
Drikite, Laura
Gruener, Beate
Icardi, Giancarlo
Kate, Gerrit Luit ten
Martin, Charlotte
Mira-Iglesias, Ainara
Orrico-Sanchez, Alejandro
Otero-Romero, Susana
Rohde, Gernot
Jodar, Luis
Mclaughlin, John M.
Bollaerts, Kaatje
ECLINICALMEDICINE, 2025, 79

← 1 2 3 4 5 →